Home > > > Atherectomy Devices Market Size to Reach USD 1,945.0 Million by 2033 Driven by Rising Prevalence of

Atherectomy Devices Market Size to Reach USD 1,945.0 Million by 2033 Driven by Rising Prevalence of

Author : Sameer Straits2 | Published On : 11 May 2026

Market Overview

The global Atherectomy Devices Market is witnessing significant growth due to the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive surgical procedures, and growing demand for advanced plaque removal technologies. Atherectomy devices are widely used to remove atherosclerotic plaque from blood vessels, helping restore blood flow in patients suffering from coronary artery disease and peripheral arterial disease.

According to the latest report by Straits Research, the global atherectomy devices market was valued at USD 1,054.6 million in 2024 and is projected to reach USD 1,945.0 million by 2033, registering a CAGR of 6.7% during the forecast period.

The market growth is primarily driven by increasing incidences of obesity, diabetes, hypertension, and other lifestyle-related cardiovascular disorders. Additionally, technological advancements in catheter-based interventions and increasing preference for minimally invasive treatment options are accelerating market expansion globally.

Request a free sample report featuring detailed market analysis, strategic insights, and industry forecasts here: https://straitsresearch.com/report/atherectomy-devices-market/request-sample

Market Dynamics

Rising Burden of Cardiovascular Diseases

The growing prevalence of coronary artery disease and peripheral arterial disease is significantly driving demand for atherectomy procedures worldwide. Sedentary lifestyles, smoking, unhealthy dietary habits, and aging populations are contributing to the increasing number of patients requiring vascular interventions.

Healthcare providers are increasingly adopting atherectomy devices as they offer effective plaque removal, reduced recovery times, and improved procedural outcomes compared to traditional surgical methods. The growing awareness regarding early diagnosis and treatment of cardiovascular conditions is further supporting market growth.

Technological Advancements in Minimally Invasive Vascular Procedures

Manufacturers are continuously introducing advanced atherectomy devices featuring improved catheter flexibility, enhanced precision, and real-time imaging capabilities. Technologies such as laser ablation atherectomy, orbital atherectomy, and rotational atherectomy are gaining widespread popularity due to their ability to improve procedural efficiency and patient safety.

Additionally, increasing integration of imaging technologies and minimally invasive cardiovascular interventions is transforming vascular treatment procedures globally. Continuous investments in medical device innovation and interventional cardiology technologies are creating substantial growth opportunities across the healthcare industry.

Explore comprehensive market intelligence, emerging trends, competitive developments, and future growth opportunities here: https://straitsresearch.com/report/atherectomy-devices-market

Segmental Analysis

Based on type, the market is segmented into Excisional Atherectomy, Laser Ablation Atherectomy, Orbital Atherectomy, and Rotational Atherectomy.

Rotational Atherectomy dominates the market due to its widespread adoption in treating calcified arterial lesions and complex coronary artery diseases. Laser ablation atherectomy is also witnessing strong growth owing to increasing demand for precise plaque removal procedures and improved treatment outcomes.

By application, the market is categorized into Coronary Artery Disease, Peripheral Arterial Disease, and Others.

Coronary Artery Disease holds a significant market share due to the rising incidence of heart-related disorders and increasing demand for minimally invasive cardiovascular interventions. Peripheral arterial disease applications are also experiencing steady growth owing to increasing prevalence of diabetes-related vascular complications and aging populations.

Based on end-user, the market is segmented into Hospitals, Ambulatory Surgery Centres, and Others.

Hospitals dominate the market due to advanced cardiovascular treatment infrastructure, availability of skilled medical professionals, and increasing number of vascular intervention procedures performed in hospital settings. Ambulatory surgery centres are also witnessing substantial growth owing to rising preference for cost-effective outpatient treatment services and shorter hospital stays.

Regional Insights

North America dominates the global atherectomy devices market due to advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and increasing adoption of technologically advanced vascular intervention procedures.

Europe represents another significant market driven by rising geriatric population, increasing healthcare expenditure, and growing awareness regarding minimally invasive cardiovascular treatments.

The Asia-Pacific region is expected to witness substantial growth during the forecast period owing to expanding healthcare infrastructure, rising incidence of cardiovascular disorders, and increasing adoption of advanced interventional cardiology technologies across countries such as China, India, Japan, and South Korea.

Latin America and the Middle East & Africa are also emerging as promising markets due to improving healthcare accessibility, growing investments in cardiovascular care infrastructure, and increasing awareness regarding vascular disease treatment options.

Competitive Landscape

The global atherectomy devices market is highly competitive, with major companies focusing on advanced catheter technologies, minimally invasive treatment innovations, strategic partnerships, and expansion of cardiovascular intervention product portfolios to strengthen their market presence.

Major companies operating in the market include:

  • AngioDynamics

  • Abbott Laboratories

  • Braun SE

  • Biomerics LLC

  • Boston Scientific Corporation

  • Becton, Dickinson and Company

  • Cardinal Health Inc.

  • Cardiovascular Systems Inc.

  • Koninklijke Philips NV

  • Medtronic

  • RA Medical

  • Terumo Corporation

  • BIOTRONIK

  • R. Bard

  • Straub Medical

These companies are increasingly investing in advanced atherectomy systems, imaging-guided intervention technologies, precision vascular treatment solutions, and healthcare innovation initiatives to improve patient outcomes and strengthen their global market footprint.

Conclusion

The global atherectomy devices market is expected to witness strong growth over the coming years, driven by rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive vascular procedures, and continuous advancements in interventional cardiology technologies. Growing awareness regarding cardiovascular health and expanding access to advanced treatment solutions are anticipated to create substantial growth opportunities for market participants worldwide.